Literature DB >> 20388740

The PTPN22 susceptibility risk variant is not associated with the rate of joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis.

J A B van Nies, R Knevel, N Daha, M P M van der Linden, P K Gregersen, M Kern, S le Cessie, J J Houwing-Duistermaat, T W J Huizinga, R E M Toes, A H M van der Helm-van Mil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20388740      PMCID： PMC3118039          DOI： 10.1136/ard.2009.117952

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort.

Authors:  J Wesoly; A H M van der Helm-van Mil; R E Toes; A P Chokkalingam; V E H Carlton; A B Begovich; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2005-09

2.  Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

Authors:  Benedicte A Lie; Marte K Viken; Sigrid Odegård; Désirée van der Heijde; Robert Landewé; Till Uhlig; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

3.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

4.  Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Authors:  E W Karlson; L B Chibnik; J Cui; R M Plenge; R J Glass; N E Maher; A Parker; R Roubenoff; E Izmailova; J S Coblyn; M E Weinblatt; N A Shadick
Journal:  Ann Rheum Dis       Date:  2007-07-31       Impact factor: 19.103

5.  Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.

Authors:  Michael P M van der Linden; Anouk L Feitsma; Saskia le Cessie; Marlena Kern; Lina M Olsson; Soumya Raychaudhuri; Ann B Begovich; Monica Chang; Joseph J Catanese; Fina A S Kurreeman; Jessica van Nies; Désirée M van der Heijde; Peter K Gregersen; Tom W J Huizinga; René E M Toes; Annette H M van der Helm-Van Mil
Journal:  Arthritis Rheum       Date:  2009-08

Review 6.  The Leiden Early Arthritis Clinic.

Authors:  J van Aken; J H van Bilsen; C F Allaart; T W Huizinga; F C Breedveld
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

7.  The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome.

Authors:  H Naseem; W Thomson; A Silman; J Worthington; D Symmons; A Barton
Journal:  Ann Rheum Dis       Date:  2007-07-31       Impact factor: 19.103

8.  Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status.

Authors:  I Marinou; J Healy; D Mewar; D J Moore; M C Dickson; M H Binks; D S Montgomery; K Walters; A G Wilson
Journal:  Arthritis Rheum       Date:  2007-08
  8 in total
  1 in total

Review 1.  Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.

Authors:  Nunzio Bottini; Erik J Peterson
Journal:  Annu Rev Immunol       Date:  2013-12-18       Impact factor: 28.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.